Enanta Pharmaceuticals reported $417.85M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acorda Therapeutics ACOR:US $ 190.48M 15.8M
Amgen AMGN:US $ 8247M 1087M
Anika Therapeutics ANIK:US $ 286.8M 10.15M
Arrowhead Research ARWR:US $ 436.89M 8.66M
AstraZeneca AZN:LN 15676M 1246M
Biocryst Pharmaceuticals BCRX:US $ -106.08M 31.09M
Biogen BIIB:US $ 10751.9M 69.7M
Bristol Myers Squibb BMY:US $ 36808M 797M
Clovis Oncology CLVS:US $ -206.98M 14.06M
Enanta Pharmaceuticals ENTA:US $ 417.85M 18.18M
Gilead Sciences GILD:US $ 19710M 758M
GlaxoSmithKline GSK:LN 15377M 512M
Halozyme Therapeutics HALO:US $ 119.75M 52.15M
Heron Therapeutics HRTX:US $ 160.11M 36.11M
Insmed INSM:US $ 531.05M 329.42M
Intercept Pharmaceuticals ICPT:US $ -203.2M 3.2M
IONIS PHARMACEUT IONS:US $ 582.67M 97.89M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Ligand Pharmaceuticals LGND:US $ 786.52M 40.68M
Marinus Pharmaceuticals MRNS:US $ 95.06M 20.27M
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Novartis NOVN:VX SF 54042M 3519M
Novavax NVAX:US $ 745.56M 293.56M
Ptc Therapeutics PTCT:US $ 196.58M 96M
Sarepta Therapeutics SRPT:US $ 485.11M 50.34M
Vertex Pharmaceuticals VRTX:US $ 9196.4M 216.14M
Vital Therapies VTL:US $ 120.74M 16.7M
YTE INCY:US $ 2935.86M 208.02M